In this study, we found that chondrosarcoma cell lines are variably sensitive towards single PARP inhibitor treatment irrespective of IDH mutation status, with 4 out of 10 cell lines harboring similar GR50 or IC50 values as cell lines with known DNA repair deficiencies [25,26,27]. Here, IDH2 is linked to chondrosarcoma.